The ESMO Targeted Anticancer Therapies (TAT) Congress 2027 brings together global experts to accelerate early drug development and innovation in targeted cancer therapies, advancing the next generation of treatments for patients worldwide.
Key Topics
Immunotherapy
Artificial intelligence and digital therapeutics
Antibody-based therapies
Cellular and gene therapies
DNA damage repair and epigenetics
Kinase-targeting agents and cell signalling modulators
Molecular profiling applications
Methodological, financial and regulatory aspects
Who should Attend
Researchers and scientists in oncology and pharmacology
Pharmaceutical and biotechnology industry leaders
Investors and venture capital professionals
Regulatory and policy experts
Clinical development and translational medicine specialists
Healthcare innovators and digital therapeutics developers
